Vera Therapeutics, Inc. Research And Development Expense

• Vera Therapeutics, Inc. showed an increase of +70.6% in Research And Development Expense from 2024 to 2025.
• This data is from Vera Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
• XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 6 years of available data (2020 to 2025), Vera Therapeutics, Inc.'s Research And Development Expense has grown by 376.2%.
• Historical annual values: Fiscal year 2025: $215.26 million | Fiscal year 2024: $126.17 million | Fiscal year 2023: $78.23 million | Fiscal year 2022: $68.99 million | Fiscal year 2021: $22.48 million | Fiscal year 2020: $45.21 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026